Countries China
Headquartered in Beijing, China, Sino Biological is the world’s leading provider of mammalian cell-based recombinant proteins, antibodies, and relate...
October 10, 2023 | News
MENA and South Asia are recognized as pivotal regions for Kexing Biopharm's overseas business expansion. The event brought together industry experts and he...
October 10, 2023 | News
CANbridge Pharmaceuticals Inc. (1228.HK), a global biopharmaceutical company, with a foundation in China, committed to the research, development ...
October 09, 2023 | News
nnovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality med...
October 09, 2023 | News
“NMPA certification is a major step forward for Nortech Systems and our customers in the region,” said Nortech Systems CEO, Jay D. Miller. &ldq...
October 05, 2023 | News
Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, resear...
October 04, 2023 | News
Pombiliti™, a recombinant human GAA enzyme (rhGAA) naturally expressed with high levels of bis-M6P (Mannose 6-Phosphate), was started at WuXi Biologi...
October 02, 2023 | News
The clinical trial (CTR20232677) is to evaluate the safety, tolerability, preliminary efficacy, and pharmacokinetic profile of 9MW2821 in combination with ...
September 29, 2023 | News
HitGen will utilize its DNA-encoded library (DEL) technology platform, specifically OpenDEL™, to screen under-represented targets chosen by SGC. &nbs...
September 29, 2023 | News
BioCity will lead the trial, which has received IND approval by the National Medical Products Administration (NMPA). The study will be conducted at Zhongsh...
September 28, 2023 | News
The launch of the new base in Shanghai will enhance OBiO's production and service capabilities in both China and the United States...
September 28, 2023 | News
United States and Mainland China continue to lead innovation and remain at the forefront of AI technology advancement for drug discovery C...
September 28, 2023 | News
Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces the completion of enrollment of 120 patients in the Phase III registration clinical trial of ...
September 27, 2023 | News
The opening will add drug substance and drug product capacity, with end-to-end services for diversified vaccines that will accelerate global clients' proje...
September 27, 2023 | News
Most Read
Bio Jobs
News
Editor Picks